Past Lectures

Date Speaker(s) Presentation Title Sort ascending
October 2016

Alan G. Nyitray, Ph.D.
National Cancer Institute

The Epidemiology of Anal HPV in High Risk Men and Novel Opportunities for Anal Cancer Screening
April 2015

S. Yousuf Zafar, M.D., M.H.S.
Duke Medical Oncology

The Elephant in the Room: How High Cost is Harming Cancer Care
February 2018

B.R. Simon Rosser, Ph.D., M.P.H.
Professor, Division of Epidemiology & Community Health; Director, HIV/STI Intervention & Prevention Studies; University of Minnesota School of Public Health Minneapolis, MN

The Effects of Prostate Cancer Treatment on the Sexual Behavior of Gay and Bisexual Men: Key Results from the "Restore" Study
May 2016

Sarah Gehlert, Ph.D.
Washington University in St. Louis

The Effect of Social Influences on African-American Breast Cancer Patients
December 2015

Norma Fox Kanarek, Ph.D., M.P.H.
Johns Hopkins School of Public Health

State Cancer Plans, Cancer Centers and Population Health: Tools or Toolbox?
April 2023
Yelena Wu, Ph.D.

Yelena Wu, Ph.D.
Huntsman Cancer Institute, University of Utah

Skin cancer prevention among young adults: The Risk Information and Skin-cancer Education for Undergraduate Prevention study
May 2016

Nancy Krieger, Ph.D.
Boston University

Segregation, Jim Crow, Racism, Embodied History & the People’s Health: Implications for Cancer Registries, Research & Prevention
March 2018

Philip E. Castle, Ph.D., M.P.H.
Professor, Department of Epidemiology and Population Health, Albert Einstein College of Medicine Global Health Center Bronx, NY

Screening for the Prevention of Cervical Cancer: The Good, the Bad, and the Ugly
June 2018

Nickolas Papadopoulos, Ph.D.
Professor of Oncology and Pathology; Director of Translational Genetics; Ludwig Center for Cancer Genetics & Therapeutics; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Institutions, Baltimore, MD

Role of non-Invasive Tests for the Early Detection of Cancer
October 2018

Amy Abernethy, M.D., Ph.D.
Flatiron Health

Research at Scale: Rethinking evidence generation for the 21st Century